dr. reddy's labs glp-1 receptor agonist medications has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month Beyond GLP-1: New 5-In-1 Compound
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


















.png?w=1536&max-h=2752&fit=crop&auto=format)






